ClinicalTrials.gg
CompletedNCT06390917Updated Sep 15, 2026

Study on the Patient-Ventilator Asynchrony Analysis Function

An interventional study of PVA recognition function in To Study the Incidence of Patient-ventilator Asynchronization in Two Groups of Patients Under Two Conditions With PVA Unsynchronization Analysis Function, sponsored by Ming Zhong. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by Ming Zhong · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

In this study, the incidence of patient-ventilator asynchronism in two groups of patients was studied when the ventilator was prompted by the PVA asynchronism analysis function

Read the detailed description

Incidence of patient-computer dyssynchrony events: defined as the proportion of patient-computer dyssynchrony events in the total number of cycles during the patient trial. The observation period began 48 hours after the participants met the inclusion and exclusion criteria and signed the informed consent, and the data collection was stopped 48 hours later.

02

Conditions studied

  • To Study the Incidence of Patient-ventilator Asynchronization in Two Groups of Patients Under Two Conditions With PVA Unsynchronization Analysis Function
03

In context

Lead sponsor

Ming Zhong is the lead sponsor of 4 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adults (≥18 years) requiring invasive mechanical ventilation
  2. Patiens had spontaneous breathing;
  3. Agreed to participate in the trial and signed an

Exclusion criteria

Exclusion Criteria:

  1. Patients with to esophageal catheter insertion and inability to monitor esophageal pressure;
  2. pregnant women;
  3. patients with severe central nervous system damage or neuromuscular related diseases;
  4. Participating in other clinical research projects;
  5. Patients deemed unsuitable by the investigator
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    With PVAs group

    With the assistance of PVA function, researchers identify the patient-ventilator asynchronies and take actions to reduce the asynchronies.

    Device: PVA recognition function

  • No intervention
    Without PVAs group

    PVA function is not utilized in this arm, researchers identify the patient-ventilator asynchronies by their own and take actions to reduce the asynchronies.

Interventions

  • DevicePVA recognition function

    Ventilator with the function of identify and judge PVAs

06

What researchers measure

Primary outcomes

  1. Incidence rate of PVAs

    Percentage of the number of respiratory cycles in which human-machine asynchronous events occurred in the total number of respiratory cycles in each patient during the trial

    Time frame: 48 hours

Secondary outcomes

  1. The proportion of PVAs that were identified by the investigator among the total PVAs during the trial

    Time frame: 48 hours

  2. Incidence of PVA within half an hour before and after the intervention

    Time frame: Half an hour before and after the intervention

  3. Accuracy of PVA recognition function

    Compare manual audit and machine judgment

    Time frame: 48 hours

07

Study locations

1 site
  • 180 Fenglin Road
    Shanghai, 20032, China
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2024 to primary completion in Apr 2025, 12 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 18, 2024
First posted
Apr 30, 2024
StartActual
Apr 15, 2024
Primary completionActual
Apr 26, 2025
CompletionActual
Apr 30, 2025
Last update
Sep 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06390917
Lead sponsor
Ming Zhong
Responsible party
Ming Zhong (Professor, Shanghai Zhongshan Hospital) — Sponsor-investigator
First posted
Apr 30, 2024
Start date
Apr 15, 2024
Primary completion
Apr 26, 2025
Completion
Apr 30, 2025
Last update
Sep 15, 2026

Study contacts

Ming Zhong
principal investigator · Shanghai Zhongshan Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion